SG11202110947RA - Functionalized ubx protein materials for enhanced purification of antibodies - Google Patents

Functionalized ubx protein materials for enhanced purification of antibodies

Info

Publication number
SG11202110947RA
SG11202110947RA SG11202110947RA SG11202110947RA SG11202110947RA SG 11202110947R A SG11202110947R A SG 11202110947RA SG 11202110947R A SG11202110947R A SG 11202110947RA SG 11202110947R A SG11202110947R A SG 11202110947RA SG 11202110947R A SG11202110947R A SG 11202110947RA
Authority
SG
Singapore
Prior art keywords
functionalized
antibodies
protein materials
enhanced purification
ubx protein
Prior art date
Application number
SG11202110947RA
Inventor
Sarah E Bondos
David W Howell
Original Assignee
Bondwell Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bondwell Tech Inc filed Critical Bondwell Tech Inc
Publication of SG11202110947RA publication Critical patent/SG11202110947RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
SG11202110947RA 2019-04-02 2020-04-02 Functionalized ubx protein materials for enhanced purification of antibodies SG11202110947RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962828142P 2019-04-02 2019-04-02
PCT/US2020/026412 WO2020206138A1 (en) 2019-04-02 2020-04-02 Functionalized ubx protein materials for enhanced purification of antibodies

Publications (1)

Publication Number Publication Date
SG11202110947RA true SG11202110947RA (en) 2021-10-28

Family

ID=70476359

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110947RA SG11202110947RA (en) 2019-04-02 2020-04-02 Functionalized ubx protein materials for enhanced purification of antibodies

Country Status (9)

Country Link
US (1) US20220251147A1 (en)
EP (1) EP3947473A1 (en)
JP (1) JP2022521648A (en)
KR (1) KR20220004656A (en)
CN (1) CN113924320A (en)
AU (1) AU2020253470A1 (en)
CA (1) CA3135846A1 (en)
SG (1) SG11202110947RA (en)
WO (1) WO2020206138A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739673D1 (en) 1996-11-27 2009-12-31 Genentech Inc Affinity Purification of Polypeptide Proteins on a Protein A Matrix
JP4599355B2 (en) 2003-07-28 2010-12-15 ジェネンテック， インコーポレイテッド Reduction of protein A leaching during protein A affinity chromatography
DE102004049479A1 (en) * 2004-10-11 2006-04-13 Scil Proteins Gmbh Protein conjugates for use in therapy, diagnosis and chromatography
US8592555B2 (en) * 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
WO2010057032A2 (en) * 2008-11-14 2010-05-20 The Texas A & M University System Self-assembly of protein-based biomaterials with multiple morphologies
WO2012074463A1 (en) * 2010-11-29 2012-06-07 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
WO2016118538A1 (en) 2015-01-19 2016-07-28 The Texas A&M University System Functionalized protein-based materials and their uses
US11739118B2 (en) * 2017-02-15 2023-08-29 Bioprocessia Technologies Llc Affinity chromatography ligands with mild elution pH

Also Published As

Publication number Publication date
AU2020253470A1 (en) 2021-11-04
JP2022521648A (en) 2022-04-11
CN113924320A (en) 2022-01-11
KR20220004656A (en) 2022-01-11
CA3135846A1 (en) 2020-10-08
EP3947473A1 (en) 2022-02-09
US20220251147A1 (en) 2022-08-11
WO2020206138A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
SG11202108141VA (en) Novel cd40-binding antibodies
EP3893931A4 (en) Methods of using anti-trem2 antibodies
EP3092002A4 (en) Method of purifying monoclonal antibodies
GB2575261B (en) Intermediates in the synthesis of C3-substituted cephalosporins
EP4034568A4 (en) Novel anti-pd-l1 antibodies
SG11202110947RA (en) Functionalized ubx protein materials for enhanced purification of antibodies
EP3867272A4 (en) Use of anti-fam19a5 antibodies
EP3624791A4 (en) Reagent for site-selective bioconjugation of proteins or antibodies
IL289959A (en) Methods for purifying antibodies
EP4081546A4 (en) Novel anti-fgfr2b antibodies
EP4081547A4 (en) Novel anti-fgfr2b antibodies
IL277056A (en) Methods for purifying antibodies
GB201911685D0 (en) Process for purifying monoclonal antibodies
IL287756A (en) Methods of making antibodies
GB202010760D0 (en) Novel antibodies
GB202002581D0 (en) Novel antibodies
EP4081539A4 (en) Novel anti-fgfr2b antibodies
IL276816A (en) Antibody purification
GB201911799D0 (en) Novel Antibodies
GB201911798D0 (en) Novel antibodies
IL310409A (en) Large scale purification of antibodies
IL290300A (en) Novel composition comprising antibodies
GB202308898D0 (en) Anti-fibril antibodies
GB202308884D0 (en) Anti-fibril antibodies
GB202306874D0 (en) Antibodies